We are live on
!
Find out more
CVSC
C.V. Starr & Co Portfolio holdings
AUM
$192M
1-Year Est. Return
35.69%
This Fund
S&P 500
This Quarter
Est. Return
+65.17%
1 Year Est. Return
+35.69%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.4M
AUM Growth
+$44.3M
(+163%)
Cap. Flow
+$19.9M
Cap. Flow
% of AUM
27.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celularity
CELU
|
+$19.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.16% |
| 2 | Consumer Discretionary | 6.84% |
Similar funds
CA
AGA
VFA
KWM
SCGDR
KC
CCC
WIA
C.V. Starr & Co's Q1 2022 Portfolio in Review
As of Q1 2022, C.V. Starr & Co held 2 positions worth $71.4M, up 163% from $27.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
C.V. Starr & Co deployed $19.9M of net new capital in Q1 2022, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 82% a quarter earlier, followed by Consumer Discretionary.
- C.V. Starr & Co added most to Celularity in Q1 2022, an estimated $19.9M increase.
- C.V. Starr & Co's ten largest holdings make up 100% of its $71.4M portfolio in Q1 2022.
- C.V. Starr & Co opened 0 new positions and closed 0 in Q1 2022.
- C.V. Starr & Co's portfolio value rose 163% quarter-over-quarter to $71.4M.
Based on C.V. Starr & Co's 13F filing for Q1 2022, filed 11 May 2022.